BTN1A1
geneOn this page
Also known as BTBTN1
Summary
BTN1A1 (butyrophilin subfamily 1 member A1, HGNC:1135) is a protein-coding gene on chromosome 6p22.2, encoding Butyrophilin subfamily 1 member A1 (Q13410). May function in the secretion of milk-fat droplets.
Butyrophilin is the major protein associated with fat droplets in the milk. It is a member of the immunoglobulin superfamily. It may have a cell surface receptor function. The human butyrophilin gene is localized in the major histocompatibility complex (MHC) class I region of 6p and may have arisen relatively recently in evolution by the shuffling of exons between 2 ancestral gene families
Source: NCBI Gene 696 — RefSeq curated summary.
At a glance
- GWAS associations: 28
- Clinical variants (ClinVar): 77 total
- MANE Select transcript:
NM_001732
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:1135 |
| Approved symbol | BTN1A1 |
| Name | butyrophilin subfamily 1 member A1 |
| Location | 6p22.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | BT, BTN1 |
| Ensembl gene | ENSG00000124557 |
| Ensembl biotype | protein_coding |
| OMIM | 601610 |
| Entrez | 696 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000244513, ENST00000684113
RefSeq mRNA: 1 — MANE Select: NM_001732
NM_001732
CCDS: CCDS4614
Canonical transcript exons
ENST00000684113 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000703576 | 26501590 | 26501937 |
| ENSE00000703580 | 26506683 | 26506832 |
| ENSE00000848291 | 26504925 | 26505206 |
| ENSE00001038847 | 26508061 | 26508087 |
| ENSE00001233265 | 26507950 | 26507970 |
| ENSE00003919829 | 26501230 | 26501365 |
| ENSE00003920232 | 26500303 | 26500358 |
| ENSE00003921633 | 26508501 | 26510425 |
Expression profiles
Bgee: expression breadth broad, 33 present calls, max score 92.22.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0159 / max 7.3217, expressed in 5 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 66532 | 0.0159 | 5 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 92.22 | gold quality |
| pancreatic ductal cell | CL:0002079 | 58.28 | silver quality |
| colonic epithelium | UBERON:0000397 | 54.80 | gold quality |
| bone marrow cell | CL:0002092 | 54.67 | gold quality |
| lymph node | UBERON:0000029 | 54.27 | gold quality |
| tibialis anterior | UBERON:0001385 | 54.03 | silver quality |
| ileal mucosa | UBERON:0000331 | 51.72 | silver quality |
| deltoid | UBERON:0001476 | 51.59 | gold quality |
| vermiform appendix | UBERON:0001154 | 50.96 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 50.90 | gold quality |
| caecum | UBERON:0001153 | 49.63 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| blood vessel layer | UBERON:0004797 | 49.29 | gold quality |
| quadriceps femoris | UBERON:0001377 | 49.26 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| hair follicle | UBERON:0002073 | 49.18 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 48.89 | gold quality |
| myocardium | UBERON:0002349 | 48.87 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
| oviduct epithelium | UBERON:0004804 | 48.56 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 48.55 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 48.50 | gold quality |
| vastus lateralis | UBERON:0001379 | 48.25 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 48.24 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 48.20 | gold quality |
| upper arm skin | UBERON:0004263 | 48.06 | gold quality |
| cervix epithelium | UBERON:0004801 | 48.04 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 47.92 | gold quality |
| stromal cell of endometrium | CL:0002255 | 47.88 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-36552 | yes | 87.73 |
| E-ENAD-17 | no | 10.12 |
| E-ANND-3 | no | 3.59 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): SOX9
miRNA regulators (miRDB)
49 targeting BTN1A1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-103A-3P | 99.98 | 69.14 | 1595 |
| HSA-MIR-107 | 99.98 | 69.14 | 1595 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-497-5P | 99.92 | 71.83 | 2674 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-15A-5P | 99.90 | 72.80 | 2787 |
| HSA-MIR-15B-5P | 99.90 | 72.78 | 2798 |
| HSA-MIR-16-5P | 99.90 | 72.80 | 2780 |
| HSA-MIR-195-5P | 99.90 | 72.81 | 2805 |
| HSA-MIR-6838-5P | 99.89 | 71.94 | 2690 |
| HSA-MIR-424-5P | 99.89 | 71.90 | 2641 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-5004-5P | 99.68 | 66.63 | 1294 |
| HSA-MIR-5093 | 99.67 | 69.26 | 2291 |
| HSA-MIR-875-3P | 99.63 | 69.47 | 2548 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
| HSA-MIR-7159-5P | 99.53 | 72.12 | 2472 |
| HSA-MIR-6833-5P | 99.50 | 68.93 | 1161 |
| HSA-MIR-3911 | 99.38 | 66.95 | 1087 |
| HSA-MIR-6505-3P | 99.34 | 67.39 | 1071 |
| HSA-MIR-4721 | 99.26 | 66.05 | 818 |
| HSA-MIR-4279 | 99.19 | 66.70 | 2437 |
| HSA-MIR-3125 | 99.14 | 68.49 | 2269 |
Literature-anchored findings (GeneRIF, showing 3)
- PRY/SPRY/B30.2 domain of butyrophilin 1A1 (BTN1A1) binds to xanthine oxidoreductase (PMID:19531472)
- Data illustrated the importance of Akt1 in mammary epithelial cell proliferation, as well as in the regulation of Btn1a1 and subsequent expression of ss-casein. (PMID:21915327)
- BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1. (PMID:38485289)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Btn1a1 | ENSMUSG00000000706 |
| rattus_norvegicus | Btn1a1 | ENSRNOG00000017514 |
Paralogs (15): BTN3A1 (ENSG00000026950), CD276 (ENSG00000103855), BTN3A3 (ENSG00000111801), BTN2A1 (ENSG00000112763), BTNL8 (ENSG00000113303), HHLA2 (ENSG00000114455), BTN2A2 (ENSG00000124508), VTCN1 (ENSG00000134258), ICOSLG (ENSG00000160223), ERMAP (ENSG00000164010), BTNL9 (ENSG00000165810), BTNL3 (ENSG00000168903), BTN3A2 (ENSG00000186470), BTNL2 (ENSG00000204290), MOG (ENSG00000204655)
Protein
Protein identifiers
Butyrophilin subfamily 1 member A1 — Q13410 (reviewed: Q13410)
All UniProt accessions (1): Q13410
UniProt curated annotations — full annotation on UniProt →
Function. May function in the secretion of milk-fat droplets. May act as a specific membrane-associated receptor for the association of cytoplasmic droplets with the apical plasma membrane. Inhibits the proliferation of CD4 and CD8 T-cells activated by anti-CD3 antibodies, T-cell metabolism and IL2 and IFNG secretion.
Subunit / interactions. Seems to associate with xanthine dehydrogenase/oxidase.
Subcellular location. Membrane. Secreted.
Post-translational modifications. N-glycosylated.
Similarity. Belongs to the immunoglobulin superfamily. BTN/MOG family.
RefSeq proteins (1): NP_001723* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001870 | B30.2/SPRY | Domain |
| IPR003599 | Ig_sub | Domain |
| IPR003877 | SPRY_dom | Domain |
| IPR003879 | Butyrophylin_SPRY | Domain |
| IPR006574 | PRY | Domain |
| IPR007110 | Ig-like_dom | Domain |
| IPR013106 | Ig_V-set | Domain |
| IPR013320 | ConA-like_dom_sf | Homologous_superfamily |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR036179 | Ig-like_dom_sf | Homologous_superfamily |
| IPR037958 | SPRY/PRY_BTN1/2 | Domain |
| IPR043136 | B30.2/SPRY_sf | Homologous_superfamily |
| IPR050504 | IgSF_BTN/MOG-like | Family |
| IPR053896 | BTN3A2-like_Ig-C | Domain |
Pfam: PF00622, PF07686, PF13765, PF22705
UniProt features (19 total): sequence variant 4, domain 3, compositionally biased region 2, glycosylation site 2, disulfide bond 2, topological domain 2, signal peptide 1, chain 1, transmembrane region 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q13410-F1 | 84.67 | 0.65 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (2): 50–124, 164–218
Glycosylation sites (2): 55, 215
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-8851680 | Butyrophilin (BTN) family interactions |
| R-HSA-1280218 | Adaptive Immune System |
| R-HSA-168256 | Immune System |
MSigDB gene sets: 77 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, GOBP_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GOCC_CELL_SURFACE, GOBP_REGULATION_OF_IMMUNE_RESPONSE, GOBP_CYTOKINE_PRODUCTION, MCBRYAN_PUBERTAL_BREAST_3_4WK_UP, MODULE_99, GOBP_T_CELL_RECEPTOR_SIGNALING_PATHWAY, MORF_RAB3A, TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA, GOMF_SIGNALING_RECEPTOR_BINDING, GOCC_SIDE_OF_MEMBRANE, GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP
GO Biological Process (2): regulation of cytokine production (GO:0001817), T cell receptor signaling pathway (GO:0050852)
GO Molecular Function (3): signaling receptor binding (GO:0005102), signaling receptor activity (GO:0038023), protein binding (GO:0005515)
GO Cellular Component (5): obsolete extracellular space (GO:0005615), plasma membrane (GO:0005886), external side of plasma membrane (GO:0009897), extracellular region (GO:0005576), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Adaptive Immune System | 1 |
| Immune System | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| cytokine production | 1 |
| regulation of gene expression | 1 |
| regulation of multicellular organismal process | 1 |
| antigen receptor-mediated signaling pathway | 1 |
| protein binding | 1 |
| molecular transducer activity | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| plasma membrane | 1 |
| cell surface | 1 |
| side of membrane | 1 |
Protein interactions and networks
STRING
814 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| BTN1A1 | XDH | P47989 | 987 |
| BTN1A1 | PLIN2 | Q99541 | 972 |
| BTN1A1 | MFGE8 | Q08431 | 777 |
| BTN1A1 | CSN2 | P05814 | 660 |
| BTN1A1 | LTF | P02788 | 628 |
| BTN1A1 | MUC1 | P13931 | 610 |
| BTN1A1 | PPL | O60437 | 563 |
| BTN1A1 | CD8A | P01732 | 563 |
| BTN1A1 | MUC15 | Q8N387 | 549 |
| BTN1A1 | CSN1S1 | P47710 | 544 |
| BTN1A1 | CIDEA | O60543 | 539 |
| BTN1A1 | GOT2 | P00505 | 533 |
| BTN1A1 | LALBA | P00709 | 520 |
| BTN1A1 | CD4 | P01730 | 514 |
| BTN1A1 | PRY | O14603 | 476 |
IntAct
23 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| COPS6 | RHOBTB1 | psi-mi:“MI:0914”(association) | 0.730 |
| DCX | ZBTB5 | psi-mi:“MI:0914”(association) | 0.670 |
| BTN1A1 | MEOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BTN1A1 | MOSPD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CTLA4 | B4GALT5 | psi-mi:“MI:0914”(association) | 0.530 |
| BTN1A1 | PPL | psi-mi:“MI:0915”(physical association) | 0.400 |
| BTN1A1 | JAML | psi-mi:“MI:0915”(physical association) | 0.400 |
| BTN1A1 | NEGR1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TARM1 | BTN1A1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| METTL3 | TUBAL3 | psi-mi:“MI:0914”(association) | 0.350 |
| METTL14 | HMGB1P1 | psi-mi:“MI:0914”(association) | 0.350 |
| PLK1 | ERCC6L | psi-mi:“MI:0914”(association) | 0.350 |
| NME5 | INPPL1 | psi-mi:“MI:0914”(association) | 0.350 |
| TRIM11 | LYPLA1 | psi-mi:“MI:0914”(association) | 0.350 |
| ATG4A | RAB13 | psi-mi:“MI:0914”(association) | 0.350 |
| ACTBL2 | BTN1A1 | psi-mi:“MI:0914”(association) | 0.350 |
| SSRP1 | FABP3 | psi-mi:“MI:0914”(association) | 0.350 |
| FHIP2A | MED19 | psi-mi:“MI:2364”(proximity) | 0.270 |
| BTN1A1 | MEOX2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MOSPD2 | BTN1A1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (18): BTN1A1 (Affinity Capture-MS), BTN1A1 (Affinity Capture-MS), BTN1A1 (Affinity Capture-MS), BTN1A1 (Affinity Capture-MS), BTN1A1 (Two-hybrid), MOSPD2 (Two-hybrid), BTN1A1 (Affinity Capture-MS), BTN1A1 (Affinity Capture-MS), BTN1A1 (Affinity Capture-MS), BTN1A1 (Affinity Capture-MS), BTN1A1 (Affinity Capture-MS), BTN1A1 (Protein-RNA), BTN1A1 (Affinity Capture-MS), BTN1A1 (Cross-Linking-MS (XL-MS)), BTN1A1 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A0E4BZH1, A4QPC6, A5D7V5, A7TZE6, A7TZF0, A7TZF3, A7XUX6, A7XV04, A7XV07, A8K4G0, A8MVZ5, O70355, P08508, P18892, P24071, P31994, P55803, P78410, P79391, Q13410, Q16653, Q29ZQ1, Q3KPI0, Q58DF9, Q5R7W8, Q5R960, Q5R996, Q61885, Q62556, Q63345, Q6Q8B3, Q6UXZ3, Q6XJV4, Q6XJV6, Q7KYR7, Q7TST0, Q7YR73, Q8BTP3, Q8K249, Q8TD46
Diamond homologs: A0A0E4BZH1, A4QPC6, A7TZE6, A7TZF0, A7TZF3, A7TZG1, A7TZG3, A7XUX6, A7XUY5, A7XUZ6, A7XV04, A7XV07, A7XV14, A8MVZ5, O00478, O00481, O70355, P18892, P55803, P78410, Q13410, Q16653, Q29ZQ1, Q5R7W8, Q5R960, Q5R996, Q61885, Q62556, Q63345, Q6MG97, Q6UX41, Q6UXE8, Q6UXG8, Q7KYR7, Q7TST0, Q8BJE2, Q8WVV5, Q96KV6, Q96PL5, Q9BGS7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
77 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 66 |
| Likely benign | 3 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
587 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:26501933:GGCTG:G | donor_gain | 1.0000 |
| 6:26501934:GCTGG:G | donor_gain | 1.0000 |
| 6:26501935:CTGG:C | donor_loss | 1.0000 |
| 6:26501936:TG:T | donor_gain | 1.0000 |
| 6:26501937:GG:G | donor_gain | 1.0000 |
| 6:26501938:G:GG | donor_gain | 1.0000 |
| 6:26501938:GT:G | donor_loss | 1.0000 |
| 6:26501939:T:A | donor_loss | 1.0000 |
| 6:26501940:G:GT | donor_loss | 1.0000 |
| 6:26508499:A:AG | acceptor_gain | 1.0000 |
| 6:26508500:G:GA | acceptor_gain | 1.0000 |
| 6:26501584:C:CA | acceptor_gain | 0.9900 |
| 6:26501588:A:AG | acceptor_gain | 0.9900 |
| 6:26501589:G:GG | acceptor_gain | 0.9900 |
| 6:26501941:A:AC | donor_loss | 0.9900 |
| 6:26508499:AGTT:A | acceptor_gain | 0.9900 |
| 6:26508500:GTT:G | acceptor_gain | 0.9900 |
| 6:26508500:GTTG:G | acceptor_gain | 0.9900 |
| 6:26501362:TCAGG:T | donor_loss | 0.9800 |
| 6:26501363:CAGGT:C | donor_loss | 0.9800 |
| 6:26501364:AGGTA:A | donor_loss | 0.9800 |
| 6:26501366:G:A | donor_loss | 0.9800 |
| 6:26501367:T:G | donor_loss | 0.9800 |
| 6:26501585:G:A | acceptor_gain | 0.9800 |
| 6:26501933:GGCT:G | donor_gain | 0.9800 |
| 6:26501934:GCTG:G | donor_gain | 0.9800 |
| 6:26504923:A:AG | acceptor_gain | 0.9800 |
| 6:26504924:G:GG | acceptor_gain | 0.9800 |
| 6:26504924:GCTCT:G | acceptor_gain | 0.9800 |
| 6:26505202:ACCAG:A | donor_loss | 0.9800 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000092679 (6:26503844 G>C), RS1000264076 (6:26504260 G>C,T), RS1000971796 (6:26509547 A>C), RS1001237209 (6:26505853 T>C), RS1001266921 (6:26506156 A>G), RS1001500649 (6:26502114 C>T), RS1001613720 (6:26498559 T>C), RS1001807520 (6:26505584 C>G), RS1002156712 (6:26506021 A>C), RS1002218235 (6:26500265 C>T), RS1002243035 (6:26507496 T>C), RS1002593695 (6:26499829 G>A), RS1003194323 (6:26507186 A>G), RS1003323249 (6:26499256 A>G), RS1003605133 (6:26499509 T>C,G)
Disease associations
OMIM: gene MIM:601610 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
28 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000301_8 | Iron status biomarkers | 6.000000e-08 |
| GCST004521_113 | Autism spectrum disorder or schizophrenia | 3.000000e-19 |
| GCST004521_208 | Autism spectrum disorder or schizophrenia | 5.000000e-17 |
| GCST004521_215 | Autism spectrum disorder or schizophrenia | 5.000000e-13 |
| GCST004521_301 | Autism spectrum disorder or schizophrenia | 1.000000e-08 |
| GCST004521_69 | Autism spectrum disorder or schizophrenia | 8.000000e-24 |
| GCST005316_551 | Intelligence (MTAG) | 2.000000e-11 |
| GCST005316_563 | Intelligence (MTAG) | 8.000000e-13 |
| GCST005316_627 | Intelligence (MTAG) | 1.000000e-14 |
| GCST007335_33 | Age at first sexual intercourse | 2.000000e-07 |
| GCST008152_157 | Weight | 6.000000e-06 |
| GCST008158_7 | Body mass index | 5.000000e-07 |
| GCST008396_3 | Educational attainment (years of education) | 2.000000e-08 |
| GCST008832_6 | Gastroesophageal reflux disease | 1.000000e-10 |
| GCST010002_50 | Refractive error | 4.000000e-34 |
| GCST010142_16 | Fish- and plant-related diet | 2.000000e-10 |
| GCST010142_19 | Fish- and plant-related diet | 4.000000e-10 |
| GCST010142_34 | Fish- and plant-related diet | 7.000000e-09 |
| GCST010142_35 | Fish- and plant-related diet | 8.000000e-09 |
| GCST010142_42 | Fish- and plant-related diet | 1.000000e-08 |
| GCST010142_7 | Fish- and plant-related diet | 3.000000e-12 |
| GCST010142_74 | Fish- and plant-related diet | 9.000000e-09 |
| GCST010142_82 | Fish- and plant-related diet | 3.000000e-08 |
| GCST010702_75 | Subcortical volume (MOSTest) | 3.000000e-11 |
| GCST010703_272 | Brain morphology (MOSTest) | 7.000000e-16 |
| GCST90000514_4 | Gastroesophageal reflux disease | 2.000000e-13 |
| GCST90016674_6 | Liver iron content | 1.000000e-38 |
| GCST90020028_819 | Hip circumference adjusted for BMI | 2.000000e-08 |
EFO canonical traits (9, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004461 | iron biomarker measurement |
| EFO:0004337 | intelligence |
| EFO:0009749 | age at first sexual intercourse measurement |
| EFO:0004338 | body weight |
| EFO:0004340 | body mass index |
| EFO:0004784 | self reported educational attainment |
| EFO:0008111 | diet measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation, affects cotreatment | 1 |
| glycidyl methacrylate | decreases expression | 1 |
| arsenite | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Fulvestrant | decreases methylation, affects cotreatment | 1 |
| Arsenic | affects methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_E1SG | HAP1 BTN1A1 (-) 1 | Cancer cell line | Male |
| CVCL_E1SH | HAP1 BTN1A1 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): gastroesophageal reflux disease